Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid

被引：0
|
作者：
Kridin, Khalaf [1 ,2 ,3 ]
Hammers, Christoph M. [1 ,4 ]
机构：
[1] Univ Lubeck, Lubeck Inst Expt Dermatol LIED, Lubeck, Germany
[2] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel
[3] Barch Padeh Med Ctr, Unit Dermatol & Skin Res Lab, Poriya, Israel
[4] Christian Albrechts Univ Kiel, Dept Dermatol, Kiel, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 06期
关键词：
D O I：
10.1111/bjd.21882
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：843 / 844
页数：2
相关论文
共 50 条
  • [31] Unusual flaccid blistering with mucosal involvement upon immune checkpoint inhibition Atypical bullous pemphigoid upon immune checkpoint inhibitor treatment
    Niebel, Dennis
    Braegelmann, Christine
    Wenzel, Joerg
    Bieber, Thomas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 18 (02): : 149 - 152
  • [32] Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
    Thewjitcharoen, Yotsapon
    Wanothayaroj, Ekgaluck
    Thammawiwat, Chattip
    Porramatikul, Sriurai
    Vorayingyong, Chuleekorn
    Nakasatien, Soontaree
    Krittiyawong, Sirinate
    Chanprapaph, Kumutnart
    Himathongkam, Thep
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [33] Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study
    Kawsar, Anusuya
    Edwards, Charlotte
    Patel, Pooja
    Heywood, Richard M.
    Gupta, Aakriti
    Mann, Jasmine
    Harland, Christopher
    Heelan, Kara
    Larkin, James
    Lorigan, Paul
    Harwood, Catherine A.
    Matin, Rubeta N.
    Fearfield, Louise
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (06) : 981 - 987
  • [34] Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study
    Cortazar, Frank B.
    Kibbelaar, Zoe A.
    Glezerman, Ilya G.
    Abudayyeh, Ala
    Mamlouk, Omar
    Motwani, Shveta S.
    Murakami, Naoka
    Herrmann, Sandra M.
    Manohar, Sandhya
    Shirali, Anushree C.
    Kitchlu, Abhijat
    Shirazian, Shayan
    Assal, Amer
    Vijayan, Anitha
    Renaghan, Amanda DeMauro
    Ortiz-Melo, David, I
    Rangarajan, Sunil
    Malik, A. Bilal
    Hogan, Jonathan J.
    Dinh, Alex R.
    Shin, Daniel Sanghoon
    Marrone, Kristen A.
    Mithani, Zain
    Johnson, Douglas B.
    Hosseini, Afrooz
    Uprety, Deekchha
    Sharma, Shreyak
    Gupta, Shruti
    Reynolds, Kerry L.
    Sise, Meghan E.
    Leaf, David E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (02): : 435 - 446
  • [35] Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
    Michel, L.
    Hendgen-Cotta, U. B.
    Mincu, R., I
    Helfrich, I
    Korste, S.
    Mrolzek, S. M.
    Rischpler, C.
    Herrmann, K.
    Ugurel, S.
    Zimmer, L.
    Coman, C.
    Ahrends, R.
    Schadendorf, D.
    Rassaf, T.
    Totzeck, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3260 - 3260
  • [36] Immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective and real-world study based on the United States Food and Drug Administration adverse event reporting system
    Tan, Haowen
    Chen, Xiubi
    Chen, Ying
    Ou, Xuan
    Yang, Tao
    Yan, Xida
    JOURNAL OF DERMATOLOGY, 2025, 52 (02): : 309 - 316
  • [37] Genetic Susceptibility of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in Chinese Patients with Type 2 Diabetes
    Shi, Mai
    Yang, Aimin
    Chow, Elaine
    Lau, Eric S.
    Tam, Claudia H.
    Ma, Ronald C.
    Cheung, Man Tung Christina
    Chan, Juliana C.
    Chan, Wai Sze Agnes
    DIABETES, 2022, 71
  • [38] Clinical Investigation of Immune Checkpoint Inhibitor-Associated Kidney Injury in Patients with Urologic Cancers
    Kozen N.
    Tanaka T.
    Shindo T.
    Hashimoto K.
    Kobayashi K.
    Masumori N.
    Tribologie und Schmierungstechnik, 2022, 69 (04): : 211 - 215
  • [39] Association between EKG Alterations and Clinical Outcomes in Immune Checkpoint Inhibitor-Associated Myocarditis
    Zlotoff, Daniel
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S72 - S73
  • [40] Clinical diagnosis and treatment of immune checkpoint inhibitor-associated adverse events in the digestive system
    Li, Yue
    Kang, Xiaohui
    Wang, Hanping
    Guo, Xiaoxiao
    Zhou, Jiaxin
    Duan, Lian
    Si, Xiaoyan
    Zhang, Li
    Liu, Xiaowei
    Qian, Jiaming
    Zhang, Li
    THORACIC CANCER, 2020, 11 (04) : 829 - 834
12345